|
US6207454B1
(en)
|
1989-10-16 |
2001-03-27 |
Amgen Inc. |
Method for enhancing the effciency of gene transfer with stem cell factor (SCF) polypeptide
|
|
US6248319B1
(en)
|
1989-10-16 |
2001-06-19 |
Krisztina M. Zsebo |
Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides
|
|
US6852313B1
(en)
|
1989-10-16 |
2005-02-08 |
Amgen Inc. |
Method of stimulating growth of melanocyte cells by administering stem cell factor
|
|
US7144731B2
(en)
|
1989-10-16 |
2006-12-05 |
Amgen Inc. |
SCF antibody compositions and methods of using the same
|
|
US5581476A
(en)
|
1993-01-28 |
1996-12-03 |
Amgen Inc. |
Computer-based methods and articles of manufacture for preparing G-CSF analogs
|
|
MXPA01005564A
(es)
*
|
1998-12-04 |
2003-07-14 |
Naval Medical Res Ct |
Celulas del endotelio cerebral humano en medio de crecimiento y metodo para expansion de celulas de tallo de medula osea cd34+cd38-nativas.
|
|
EP1228200A1
(en)
*
|
1999-10-27 |
2002-08-07 |
California Institute Of Technology |
Production of functional hybrid genes and proteins
|
|
US6346247B1
(en)
|
1999-10-28 |
2002-02-12 |
Promega Corporation |
Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
|
|
GB0024550D0
(https=)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
|
EP2305795B1
(en)
|
2000-12-06 |
2019-07-03 |
Celularity, Inc. |
Method of collecting placental stem cells
|
|
EP2316918B1
(en)
|
2001-02-14 |
2015-07-01 |
Anthrogenesis Corporation |
Post-partum mammalian placenta, its use and placental stem cells therefrom
|
|
PL371781A1
(en)
|
2001-07-11 |
2005-06-27 |
Maxygen Holdings, Ltd. |
G-csf conjugates
|
|
AU2003298775B2
(en)
|
2002-11-26 |
2008-07-17 |
Anthrogenesis Corporation |
Cytotherapeutics, cytotherapeutic units and methods for treatments using them
|
|
EP1888119B1
(en)
|
2005-06-01 |
2011-03-09 |
Maxygen, Inc. |
Pegylated g-csf polypeptides and methods of producing same
|
|
NZ597304A
(en)
|
2005-10-13 |
2013-06-28 |
Anthrogenesis Corp |
Immunomodulation using placental stem cells
|
|
EP1976978A2
(en)
|
2005-12-29 |
2008-10-08 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
|
PL2471907T3
(pl)
|
2005-12-29 |
2019-07-31 |
Celularity, Inc. |
Populacje komórek macierzystych łożyska
|
|
NZ612888A
(en)
|
2007-02-12 |
2015-02-27 |
Anthrogenesis Corp |
Treatment of inflammatory diseases using placental stem cells
|
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
|
RU2536242C2
(ru)
|
2007-09-28 |
2014-12-20 |
Антродженезис Корпорейшн |
Угнетение опухолей с помощью плацентарного перфузата человека и выделенных из плаценты человека вспомогательных натуральных клеток-киллеров
|
|
KR20200011604A
(ko)
|
2008-08-20 |
2020-02-03 |
안트로제네시스 코포레이션 |
개선된 세포 조성물 및 그의 제조 방법
|
|
CA2734237C
(en)
|
2008-08-20 |
2019-07-02 |
Anthrogenesis Corporation |
Treatment of stroke using isolated placental cells
|
|
CA2734446C
(en)
|
2008-08-22 |
2017-06-20 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
RU2015130665A
(ru)
|
2008-11-19 |
2018-12-24 |
Антродженезис Корпорейшн |
Амниотические адгезивные клетки
|
|
MX353489B
(es)
|
2009-07-02 |
2018-01-16 |
Anthrogenesis Corp |
Metodo para producir eritrocitos sin celulas alimentadoras.
|
|
EP2454363B1
(en)
|
2009-07-13 |
2020-07-22 |
Biogencell, Ltd. |
Method for using directing cells for specific stem/progenitor cell activation and differentiation
|
|
DK3284818T3
(da)
|
2010-01-26 |
2022-06-20 |
Celularity Inc |
Behandling af knoglerelateret kræft ved hjælp af placenta stamceller
|
|
DK2556145T3
(en)
|
2010-04-07 |
2016-11-07 |
Anthrogenesis Corp |
Angiogenesis using placental stem cells
|
|
EP2555783A1
(en)
|
2010-04-08 |
2013-02-13 |
Anthrogenesis Corporation |
Treatment of sarcoidosis using placental stem cells
|
|
MX342995B
(es)
|
2010-07-13 |
2016-10-21 |
Anthrogenesis Corp |
Métodos de generar células asesinas naturales.
|
|
WO2012092485A1
(en)
|
2010-12-31 |
2012-07-05 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory rna molecules
|
|
ES2707579T3
(es)
|
2011-06-01 |
2019-04-04 |
Celularity Inc |
Tratamiento del dolor usando citoblastos placentarios
|
|
WO2013055476A1
(en)
|
2011-09-09 |
2013-04-18 |
Anthrogenesis Corporation |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
|
US8956870B2
(en)
|
2012-01-19 |
2015-02-17 |
Biogencell, Ltd. |
Method for using directing cells for specific stem/progenitor cell activation and differentiation
|
|
RS61391B1
(sr)
|
2012-06-08 |
2021-02-26 |
Alkermes Pharma Ireland Ltd |
Ligandi modifikovani primenom cirkularnog permutiranja kao agonisti i antagonisti
|
|
AU2014215458A1
(en)
|
2013-02-05 |
2015-08-13 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
|
JPWO2023145860A1
(https=)
*
|
2022-01-27 |
2023-08-03 |
|
|